65383-57-5 Usage
Description
3-Ethoxy-4-methoxyphenol, also known as vanillyl ethyl ether, is an aromatic ether and a derivative of vanillin with the molecular formula C10H14O3. It is commonly found in natural sources such as vanilla beans and cloves and is characterized by its sweet, vanilla-like aroma.
Uses
Used in Food and Fragrance Industries:
3-Ethoxy-4-methoxyphenol is used as a flavoring agent and fragrance ingredient for its sweet, vanilla-like aroma, adding a pleasant scent to various food and beverage products.
Used in Cosmetics and Personal Care Products:
3-Ethoxy-4-methoxyphenol is used as a fragrance ingredient in cosmetics and personal care products, providing a pleasant vanilla scent and enhancing the sensory experience of these products.
Used in Antioxidant Applications:
Due to its antioxidant properties, 3-Ethoxy-4-methoxyphenol can be used as an antioxidant in food and beverage products, helping to prevent oxidation and extend the shelf life of these products.
Used in Consumer Products:
3-Ethoxy-4-methoxyphenol is used as a fragrance ingredient in a variety of consumer products, such as candles, air fresheners, and cleaning products, to provide a pleasant vanilla-like scent and improve the overall sensory experience.
Check Digit Verification of cas no
The CAS Registry Mumber 65383-57-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,3,8 and 3 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 65383-57:
(7*6)+(6*5)+(5*3)+(4*8)+(3*3)+(2*5)+(1*7)=145
145 % 10 = 5
So 65383-57-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H12O3/c1-3-12-9-6-7(10)4-5-8(9)11-2/h4-6,10H,3H2,1-2H3
65383-57-5Relevant articles and documents
METHODS OF TREATING PSYCHOLOGICAL CONDITIONS
-
Page/Page column 11-12, (2011/01/12)
A method and composition for inducing in a subject a tolerance to a psychoactive substance or for treating an abnormal mental condition in a subject. The composition used in the method comprises in one embodiment a 5-HT2B receptor agonist disposed within a pharmaceutically-acceptable vehicle or carrier.
